The State of Life Sciences Capital Markets

​Join Fenwick Life Sciences Partners Effie Toshav and Rob Freedman along with George Milstein, Managing Director and Head of Cowen’s Health Care Investment Banking Group, and Jason Fenton, Managing Director and Head of Cowen's Health Care Capital Markets, for a discussion on the current state of capital markets for life sciences companies. The discussion will explore, among other topics:

• The current state of the IPO market and economy
  
• Considerations for life sciences companies looking to go public in 2020 and 2021
• Investor focus areas
• M&A and partnering activity
• Activity levels in the public and private markets​